Year | Detail |
1986 |
Established Aurobindo Pharma Limited (APL). |
1988 - 1989 |
Commenced manufacturing semi synthetic penicillins. |
1992 - 1993 |
Started another unit was established for the manufacture of CMIC Chloride. |
1994 - 1995 |
Merged with Chaitanya Organics Pvt. Ltd. |
1997 - 1998 |
Formed an alliance with Glaxo (India) the Indian. |
1999 - 2000 |
Sri Chakra Remedies Ltd was amalgamated with Aurobindo Pharma Limited. |
2001 - 2002 |
Acquired 79% stake in Ranit Pharma Co. |
2003 - 2004 |
Joint Venture between APL and Shanxi Tongling Pharmaceuticals launched. |
2004 - 2005 |
Received US FDA clearance for AIDS drugs. |
2005 - 2006 |
Aurobindo made a strategic entry into the premium markets of U.S. and Europe. |
2007 - 2008 |
Acquired intellectual property and marketing authorizations with TAD Italy. |
2014 - 2016 |
Acquired certain commercial operations in Western Europe from Actavis Plc. |
2017 - 2018 |
Acquired Generis in Portugal. |
2019 - 2020 |
Started setting up an oral solid manufacturing facility at Taizhou for China. |
2021 |
Acquired 9 OTC brands. |